Browsing Tag
Active pharmaceutical ingredients
13 posts
Why Dai Nippon Printing chose Hyderabad for its second overseas R&D hub as 7912 retreats from 52-week highs
Dai Nippon Printing (TSE: 7912) opens an IIT Hyderabad R&D base for EV wireless charging and pharma APIs. Read the full strategic analysis.
March 23, 2026
Strait of Hormuz standoff raises risks to global supply of antibiotics, diabetes drugs, and blood pressure medicines
Strait of Hormuz closure disrupts petrochemical feedstocks and logistics for India's generic drug sector, raising US prescription supply and pricing risks.
March 16, 2026
Why Blue Jet Healthcare (NSE: BLUEJET) is spending Rs 1,000cr on Vizag while its stock hovers near IPO price
Blue Jet Healthcare breaks ground on Rs 1,000 crore Vizag API plant as BLUEJET stock trades near lows. What the Rs 2,300 crore expansion means for investors.
March 1, 2026
Inside the new plan to end U.S. dependence on foreign drug ingredients — will it work this time?
Trump orders immediate filling of U.S. strategic API reserve with domestic production focus. See how this plan aims to secure critical medicine supply.
August 14, 2025
Supriya Lifescience boosts API capacity with Rs 125cr Module E facility
Supriya Lifescience Ltd, a leading player in the pharmaceutical industry growth segment, has unveiled its latest Module E…
December 17, 2024
Supriya Lifescience, Plasma Nutrition to partner on ioProtein manufacturing in India
Mumbai-based company Supriya Lifescience Ltd, specializing in active pharmaceutical ingredients (API), has announced a groundbreaking collaboration with United…
August 2, 2023
Ami Organics wins multi-million Euro supply contract from Fermion
Ami Organics has signed a multi-year, multi-tonne agreement with Fermion, a wholly-owned subsidiary of Finland-based Orion Corporation for…
November 27, 2022
PI Industries scraps Rs 15.3bn acquisition of lnd Swift’s API unit
PI Industries Ltd (PIIND), an Indian agri-sciences company, said that its previously announced INR 1,530 crores acquisition of…
November 2, 2021
Ind-Swift Laboratories to sell Dubai subsidiary Ind-Swift Middle East to Soft Air General Trading for $1.98m
Ind-Swift Laboratories to sell Dubai-based Ind-Swift Middle East FZ-LLC to Soft Air General Trading for $1.98M. Learn key deal details and market context.
August 14, 2021
PI Industries to acquire API business of lnd Swift Laboratories
PI Industries Ltd, an Indian agri-sciences company, has agreed to acquire the API business division of lnd Swift…
July 31, 2021